BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

Markets PR Newswire By PR Newswire 27 Aug 2026 10:50 1 min read
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LITE™ Scaffold and generating evidence to support its use in breast revision surgery for capsular contracture FRANKLIN LAKES, N.J., Aug. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and...

Covered in this story

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.